相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
Tatsuo Hosoya et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Do Serum Urate-Associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK Biobank
Vicky Tai et al.
ARTHRITIS & RHEUMATOLOGY (2020)
2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy
Tristan Pascart et al.
JOINT BONE SPINE (2020)
2020 American College of Rheumatology Guideline for the Management of Gout
John D. FitzGerald et al.
ARTHRITIS CARE & RESEARCH (2020)
The biology of urate
Robert T. Keenan
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Gout: state of the art after a decade of developments
Tristan Pascart et al.
RHEUMATOLOGY (2019)
Monosodium Urate Contributes to Retinal Inflammation and Progression of Diabetic Retinopathy
Menaka C. Thounaojam et al.
DIABETES (2019)
Achievement of Target Serum Uric Acid Levels and Factors Associated with Therapeutic Failure among Japanese Men Treated for Hyperuricemia/Gout
Akiko Katayama et al.
INTERNAL MEDICINE (2019)
NLRP3 inflammasome and lipid metabolism analysis based on UPLC-Q-TOF-MS in gouty nephropathy
Yan-Zi Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Nan Liang et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Population-specific factors associated with fractional excretion of uric acid
Ravi K. Narang et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD
Anand Srivastava et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2018)
Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan
Kuang-Hui Yu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study
Milka Maravic et al.
JOINT BONE SPINE (2018)
Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis
Xuemei Liu et al.
RENAL FAILURE (2018)
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis
Lisa Stamp et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
Rulan Yin et al.
BMJ OPEN (2018)
Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
Fernando Perez Ruiz et al.
RHEUMATOLOGY AND THERAPY (2018)
An Invert U-Shaped Curve: Relationship Between Fasting Plasma Glucose and Serum Uric Acid Concentration in a Large Health Check-Up Population in China
Haibo Li et al.
MEDICINE (2016)
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Tuhina Neogi et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
An open-label, 6-month study of allopurinol safety in gout: The LASSO study
Michael A. Becker et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Decreased extra-renal urate excretion is a common cause of hyperuricemia
Kimiyoshi Ichida et al.
NATURE COMMUNICATIONS (2012)
Febuxostat in Gout: Serum Urate Response in Uric Acid Overproducers and Underexcretors
David S. Goldfarb et al.
JOURNAL OF RHEUMATOLOGY (2011)
EFFICACY OF BENZBROMARONE IN HYPERURICEMIC PATIENTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE
S. Fujimori et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
JAPANESE GUIDELINE FOR THE MANAGEMENT OF HYPERURICEMIA AND GOUT: SECOND EDITION
Hisashi Yamanaka
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2011)
2011 Recommendations for the Diagnosis and Management of Gout and Hyperuricemia
Max Hamburger et al.
PHYSICIAN AND SPORTSMEDICINE (2011)
Uric Acid-Lowering Treatment With Benzbromarone in Patients With Heart Failure A Double-Blind Placebo-Controlled Crossover Preliminary Study
Kazuhide Ogino et al.
CIRCULATION-HEART FAILURE (2010)
A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis
Rachel Halpern et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
EULAR evidence based recommendations for gout.: Part I:: Diagnosis.: Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
分享论文
